Annexon ANNX EBIT

EBIT at other companies

Regeneron PharmaceuticalsREGN

$1.29B+19.8%

Shattuck Labs, Inc.STTK

-$16.16M-24.0%

Jade BiosciencesJBIO

-$43.45M-85.8%

Dianthus TherapeuticsDNTH

-$46.53M-40.3%

Cullinan Therapeutics, Inc.CGEM

-$57.25M+24.5%

Vor BiopharmaVOR

-$35.16M-5.6%

FAQ

What is Annexon's EBIT?

Annexon (ANNX) reported EBIT of -$46.05M in Q1 2026.

How has Annexon's EBIT changed year-over-year?

Annexon's EBIT increased by 19.8% year-over-year, from -$57.41M to -$46.05M.

What is the long-term trend for Annexon's EBIT?

Over 4 years (2021 to 2025), Annexon's EBIT has grown at a 13.4% compound annual growth rate (CAGR), from -$130.71M to -$216.41M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.